Navigation Links
Impact2 EXP 6-Channel Electronic Pipettor, 2-125L

ProductsImpact2 EXP 6-Channel Electronic Pipettor, 2-125L
Company Matrix Technologies Corporation
Item Impact2 EXP 6-Channel Electronic Pipettor, 2-125L
Features 
Description Exp Expandable Tip System

A lower cost alternative to Equalizers, the patented EXP System allows you to perform multi-sample transfers between two different vessel configurations. With the push or pull of a knob, tip spacing can be quickly and easily adjusted for test tubes (and microcentrifuge tubes) or 96 well plates.

Ergonomic Design for Unparalleled Comfort
Pick one of our pipettors up and use it. Notice the balance. Notice the trigger and ejector positionsright where they should beeven if youre left-handed. Thats because our pipettors are ergonomically designed to help avoid repetitive stress injuries caused by long hours of pipetting.

Productivity In The Palm Of Your Hand
Start dispensing right away or create a program with up to 40 steps. Perform neat sample additions, simple dilutions, serial dilutions, rapid reagent additions, supernatant collections or other procedures individually or programmed in sequence according to protocol. Turn the pipettor off and it automatically remembers your most recent sequence the next time you turn it on.

Simple Calibration
In-lab calibration can be performed quickly and easily.The software provides a trail of calibration information.

Speed Control
Impact and Impact2 pipettors allow convenient on-the-fly speed control. Aspiration and dispense speeds may be individually selected from three (Impact) or five (Impact2) different settings. Impact2 features two additional slower speeds for dispensing onto electrophoresis gels.

Rechargeable, Long-Lasting Batteries
Our multichannel pipettors come with a power supply adapter and one set of NiCad batteries rated for 1200 cycles before recharging. (16-channel pipettors are provided with lithium ion batteriessee Accessories for details.) You have the option of continuing to use the pipettor while its rechargingjust plug it into the power supply and continue operation. The battery compartment is on the underside of the control panel for convenient replacement.

Info Matrix Technologies Corporation
Customer Service: (866) 229-9770
Web site: http://www.matrixtechcorp.com/index.aspx

Related medicine products :

1. Impact2 Single Channel Pipettor, 5-250L
2. Impact2 Shorty, 5-250L
3. Impact2 16-Channel Electronic Pipettor, 1.0-30L
4. Impact2 16-Channel Electronic Pipettor, 2-125L
5. Impact2 16-Channel Electronic Pipettor, 0.5-12.5L
6. Impact2 12-Channel Electronic Pipettor, 2-125L
7. Impact2 12-Channel Electronic Pipettor, 5-250L
8. Impact2 12-Channel Electronic Pipettor, 15-850L
9. Impact2 12-Channel Electronic Pipettor, 0.5-12.5L
10. Impact2 8-Channel Electronic Pipettor, 2-125L
11. Impact2 8-Channel Electronic Pipettor, 5-250L
... designed to travel a full 120 degrees, from ... wherever you release the rotating hand grip locking ... the handle with no need to ever go ... of system was designed to mimic the natural ...
Designed for Bariatric usage. Prevents arm or leg dropout during surgical procedures. Dimensions are 16"Lx10"H come in pairs. Optional gel pad available (BD2245)...
Designed to prevent arm or legs from dropouts during surgical procedures. Dimensions are 8"H x16"L. These come as pairs. Optional gel pads(BD2245)....
... Corporation offers a quality line ... to adults. Armboard covers are ... assuring easy cleaning while reducing ... Choose from three options: Disposable ...
Medicine Products:
(Date:3/5/2015)... The global digital PCR (dPCR) and qPCR market is ... from 2014 to 2019. , The global digital PCR (dPCR) and ... from 2014 to 2019. Although the mature markets such as the ... PCR (dPCR) and qPCR market the Asia-Pacific region is expected to ... The growth of the digital PCR (dPCR) and qPCR market is ...
(Date:3/5/2015)... March 05, 2015 AxoGen, Inc. ... on the peripheral nerve repair market, reported record revenue ... 31, 2014 compared to $2.98 million in the year-ago ... growth strategies. , “Our strong fourth quarter revenue ... nerve repair products which is driving increased surgeon adoption ...
(Date:3/5/2015)... March 05, 2015 Rhode Island Medical Imaging ... in a row to support the Providence College (PC) women’s ... covered the purchase of the ‘Think Pink’ uniforms, which were ... East Conference opponent DePaul University at Alumni Hall/Mullaney Gymnasium in ... our support of the PC women’s basketball’s ‘Pink Out’ event,” ...
(Date:3/5/2015)... Santa Rosa, CA (PRWEB) March 05, 2015 ... Like a SuperPro! The series aims to teach viewers ... indoor garden with hydroponics. Grow Like a SuperPro takes you ... in between. From how to clone, to how to prune ... of growing. They are offering the whole series for download ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 ... in healthcare communications and education, announced today its ... (AMP), the nation’s only medical conference designed for ... ischemia and lower limb amputation due to vascular ... family of innovative, evidence-based publications and CME activities ...
Breaking Medicine News(10 mins):Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:RIMI Teams Up with PC Women’s Basketball in the Fight Against Breast Cancer 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3
... Pollution in State , , ... today approved two diesel truck regulations that will dramatically cut ... are the first of their kind in the United States, ... estimates that the truck regulations are expected to save 9,400 ...
... heart seen, study says , , FRIDAY, Dec. 12 (HealthDay News) ... will prove to be a valuable new weapon in the ... the drug, known as lorcaserin, resulted in substantial weight loss ... completely novel mechanism and we think it can bring very ...
... Dec. 12 For every parent who wants ... gift designed to provide higher,self-confidence, better academic results ... studies have proven that early readers have,more confidence, ... and,later in life. According to a national ...
... tumor characteristics help fine-tune treatment, study says , , FRIDAY, ... in predicting breast cancer risk, recurrence risk and response ... breast density and tumor size, a panel of experts ... teleconference Friday at the annual San Antonio Breast Cancer ...
... AURORA, Ohio, Dec. 12 PartsSource, the nation,s leading,supplier of ... the 100 fastest growing companies in Ohio by the ... third year in a row.,PartsSource placed 14th on this year,s ... award each year they were eligible. , ...
... using special program saw all injuries cut by a ... -- A good warm-up program may dramatically reduce sports ... the Norwegian School of Sport Sciences found that focusing ... cut injuries by a third among almost 1,900 teenage ...
Cached Medicine News:Health News:California Rules to Cut Diesel Truck Pollution Called Most Sweeping in U.S. 2Health News:Experimental Weight-Loss Pill Passes Early Test 2Health News:Experimental Weight-Loss Pill Passes Early Test 3Health News:VIDEO from Medialink and Your Baby Can Read: Early Literacy in Children ... Proven Path to Success 2Health News:Progress Made in Predicting Breast Cancer Risk 2Health News:Progress Made in Predicting Breast Cancer Risk 3
(Date:3/5/2015)... , March 5, 2015 - ... agency ( http://www.epa.eu ) - Hitachi ... della nuova generazione di OASIS* all,ECR 2015. Si tratta ... alto campo da 1.2 T che migliora la capacità ... traguardo nell,attenzione al comfort del paziente. Le nuove funzionalità ...
(Date:3/5/2015)... DUBLIN and HAMPTON, N.J. ... (NYSE: MNK ), a leading global ... care company, announced today that they have entered into ... will acquire Ikaria, Inc. from a Madison Dearborn ... $2.3 billion. Subject to customary closing ...
(Date:3/5/2015)... , March 5, 2015  Asterias Biotherapeutics, Inc. (NYSE ... field of regenerative medicine, announced today that ... top rehabilitation hospitals for spinal cord injury and brain ... trial of AST-OPC1 (oligodendrocyte progenitor cells) in newly injured ... injury (SCI). The Phase 1/2a trial ...
Breaking Medicine Technology:Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 2Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 3Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4